Lista de obras -

A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection

artículo científico publicado en 2020

A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies

scientific article published on 10 June 2020

A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2

artículo científico publicado en 2020

A single intranasal or intramuscular immunization with chimpanzee adenovirus vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters

scientific article published on 03 December 2020

Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.

artículo científico publicado en 2017

Bruton's Tyrosine Kinase Synergizes with Notch2 To Govern Marginal Zone B Cells in Nonobese Diabetic Mice

artículo científico publicado en 2015

Bruton's tyrosine kinase promotes persistence of mature anti-insulin B cells.

artículo científico publicado en 2014

Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion

scholarly article

Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion

artículo científico publicado en 2020

Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease

artículo científico publicado en 2018

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

scientific article published on 18 May 2020

De novo design of picomolar SARS-CoV-2 miniprotein inhibitors

artículo científico publicado en 2020

Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail

artículo científico publicado en 2021

Inhibition of PIKfyve kinase prevents infection by EBOV and SARS-CoV-2

artículo científico publicado en 2020

JIB-04 Has Broad-Spectrum Antiviral Activity and Inhibits SARS-CoV-2 Replication and Coronavirus Pathogenesis

artículo científico publicado en 2022

LDLRAD3 is a receptor for Venezuelan equine encephalitis virus

artículo científico publicado en 2020

Mouse hepatitis virus nsp14 exoribonuclease activity is required for resistance to innate immunity

scientific article published on 30 August 2017

Murine hepatitis virus nsp14 exoribonuclease activity is required for resistance to innate immunity

artículo científico publicado en 2017

Mutagenesis of S-Adenosyl-l-Methionine-Binding Residues in Coronavirus nsp14 N7-Methyltransferase Demonstrates Differing Requirements for Genome Translation and Resistance to Innate Immunity.

artículo científico publicado en 2016

Mutations in coronavirus nonstructural protein 10 decrease virus replication fidelity

artículo científico publicado en 2015

Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2

artículo científico publicado en 2020

Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2

scientific article published on 03 July 2020

Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2

artículo científico publicado en 2020

Potently neutralizing and protective human antibodies against SARS-CoV-2

artículo científico publicado en 2020

Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals

artículo científico publicado en 2020

Proofreading-Deficient Coronaviruses Adapt for Increased Fitness over Long-Term Passage without Reversion of Exoribonuclease-Inactivating Mutations.

artículo científico publicado en 2017

Proofreading-deficient coronaviruses adapt over long-term passage for increased fidelity and fitness without reversion of exoribonuclease-inactivating mutations

artículo científico publicado en 2017

Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein

artículo científico publicado en 2020

Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein

artículo científico publicado en 2020

Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice

artículo científico publicado en 2020

Replication-competent vesicular stomatitis virus vaccine vector protects against SARS-CoV-2-mediated pathogenesis

scientific article published on 10 July 2020

Structural and functional analysis of a potent sarbecovirus neutralizing antibody

artículo científico publicado en 2020

The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters

Tolerant Anti-Insulin B Cells Are Effective APCs ⬇️

artículo científico publicado el 8 de febrero de 2013

Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms

artículo científico publicado en 2020

Lista de obras de

A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection

A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies

A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2

A single intranasal or intramuscular immunization with chimpanzee adenovirus vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters

Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.

Bruton's Tyrosine Kinase Synergizes with Notch2 To Govern Marginal Zone B Cells in Nonobese Diabetic Mice

Bruton's tyrosine kinase promotes persistence of mature anti-insulin B cells.

Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion

Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion

Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

De novo design of picomolar SARS-CoV-2 miniprotein inhibitors

Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail

Inhibition of PIKfyve kinase prevents infection by EBOV and SARS-CoV-2

JIB-04 Has Broad-Spectrum Antiviral Activity and Inhibits SARS-CoV-2 Replication and Coronavirus Pathogenesis

LDLRAD3 is a receptor for Venezuelan equine encephalitis virus

Mouse hepatitis virus nsp14 exoribonuclease activity is required for resistance to innate immunity

Murine hepatitis virus nsp14 exoribonuclease activity is required for resistance to innate immunity

Mutagenesis of S-Adenosyl-l-Methionine-Binding Residues in Coronavirus nsp14 N7-Methyltransferase Demonstrates Differing Requirements for Genome Translation and Resistance to Innate Immunity.

Mutations in coronavirus nonstructural protein 10 decrease virus replication fidelity

Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2

Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2

Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2

Potently neutralizing and protective human antibodies against SARS-CoV-2

Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals

Proofreading-Deficient Coronaviruses Adapt for Increased Fitness over Long-Term Passage without Reversion of Exoribonuclease-Inactivating Mutations.

Proofreading-deficient coronaviruses adapt over long-term passage for increased fidelity and fitness without reversion of exoribonuclease-inactivating mutations

Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein

Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein

Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice

Replication-competent vesicular stomatitis virus vaccine vector protects against SARS-CoV-2-mediated pathogenesis

Structural and functional analysis of a potent sarbecovirus neutralizing antibody

The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters

Tolerant Anti-Insulin B Cells Are Effective APCs ⬇️

Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms